Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Nutr Metab Cardiovasc Dis ; 27(9): 768-774, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28739184

ABSTRACT

BACKGROUND AND AIMS: Recent studies highlighted the role of calcification processes in the clinical progression of chronic cardiovascular diseases. In this study we investigated the relationship between the chemical composition of calcification and atherosclerotic plaque stability in carotid arteries. METHODS AND RESULTS: To this end, we characterized the calcification on 229 carotid plaques, by morphology, immunohistochemistry, transmission electron microscopy and energy dispersive X-ray microanalysis. Plaques were classified into two categories: unstable and stable. No significant differences were found in the incidence of the various risk factors between patients with and without carotid calcification, with the exception of diabetes. The energy dispersive X-ray microanalysis allowed us to identify two types of calcium salts in the atheromatous plaques, hydroxyapatite (HA) and calcium oxalate (CO). Our results showed that calcification is a common finding in carotid plaques, being present in 77.3% of cases, and the amount of calcium is not a factor of vulnerability. Noteworthy, we observed an association between HA calcification and unstable plaques. On the contrary, CO calcifications were mainly detected in stable plaques. CONCLUSIONS: The presence of different types of calcification in atheromatous plaques may open new perspectives in understanding the molecular mechanisms of atheroma formation and plaque instability.


Subject(s)
Calcium Oxalate/analysis , Carotid Arteries/chemistry , Carotid Artery Diseases/metabolism , Durapatite/analysis , Plaque, Atherosclerotic , Vascular Calcification/metabolism , Aged , Biomarkers/analysis , Biopsy , Carotid Arteries/ultrastructure , Carotid Artery Diseases/pathology , Disease Progression , Female , Humans , Immunohistochemistry , Male , Microscopy, Electron, Transmission , Middle Aged , Risk Factors , Rupture, Spontaneous , Spectrometry, X-Ray Emission , Vascular Calcification/pathology
2.
Sci Rep ; 5: 9023, 2015 Mar 17.
Article in English | MEDLINE | ID: mdl-25777360

ABSTRACT

Atherosclerosis is a chronic inflammatory disease characterized by the infiltration of pro-inflammatory macrophages into a lipid-laden plaque. ITCH is an E3 ubiquitin ligase that has been shown to polarize macrophages to an anti-inflammatory phenotype. We therefore investigated the effect of ITCH deficiency on the development of atherosclerosis. ApoE-/-ITCH-/- mice fed a western diet for 12 weeks showed increased circulating M2 macrophages together with a reduction in plaque formation. Bone marrow transplantation recreated the haemopoietic phenotype of increased circulating M2 macrophages but failed to affect plaque development. Intriguingly, the loss of ITCH lead to a reduction in circulating cholesterol levels through interference with nuclear SREBP2 clearance. This resulted in increased LDL reuptake through upregulation of LDL receptor expression. Furthermore, ApoE-/-ITCH-/- mice exhibit reduced hepatic steatosis, increased mitochondrial oxidative capacity and an increased reliance on fatty acids as energy source. We found that ITCH ubiquitinates SIRT6, leading to its breakdown, and thus promoting hepatic lipid infiltration through reduced fatty acid oxidation. The E3 Ubiquitin Ligase ITCH modulates lipid metabolism impacting on atherosclerosis progression independently from effects on myeloid cells polarization through control of SIRT6 and SREBP2 ubiquitination. Thus, modulation of ITCH may provide a target for the treatment of hypercholesterolemia and hyperlipidemia.


Subject(s)
Apolipoproteins E/deficiency , Atherosclerosis/genetics , Atherosclerosis/metabolism , Lipid Metabolism , Sirtuins/metabolism , Sterol Regulatory Element Binding Protein 2/metabolism , Ubiquitin-Protein Ligases/metabolism , Animals , Atherosclerosis/immunology , Atherosclerosis/pathology , Bone Marrow Transplantation , Cholesterol/blood , Cholesterol/metabolism , Disease Models, Animal , Fatty Liver/metabolism , Fatty Liver/pathology , Inflammation/genetics , Inflammation/metabolism , Liver/metabolism , Macrophages/metabolism , Mice , Mice, Knockout , Mitochondria/metabolism , Oxidation-Reduction , Ubiquitination
3.
Cell Death Dis ; 5: e1029, 2014 Jan 30.
Article in English | MEDLINE | ID: mdl-24481443

ABSTRACT

Endothelial dysfunction and impaired autophagic activity have a crucial role in aging-related diseases such as cardiovascular dysfunction and atherosclerosis. We have identified miR-216a as a microRNA that is induced during endothelial aging and, according to the computational analysis, among its targets includes two autophagy-related genes, Beclin1 (BECN1) and ATG5. Therefore, we have evaluated the role of miR-216a as a molecular component involved in the loss of autophagic function during endothelial aging. The inverse correlation between miR-216a and autophagic genes was conserved during human umbilical vein endothelial cells (HUVECs) aging and in vivo models of human atherosclerosis and heart failure. Luciferase experiments indicated BECN1, but not ATG5 as a direct target of miR-216a. HUVECs were transfected in order to modulate miR-216a expression and stimulated with 100 µg/ml oxidized low-density lipoprotein (ox-LDL) to induce a stress repairing autophagic process. We found that in young HUVECs, miR-216a overexpression repressed BECN1 and ATG5 expression and the ox-LDL induced autophagy, as evaluated by microtubule-associated protein 1 light chain 3 (LC3B) analysis and cytofluorimetric assay. Moreover, miR-216a stimulated ox-LDL accumulation and monocyte adhesion in HUVECs. Conversely, inhibition of miR-216a in old HUVECs rescued the ability to induce a protective autophagy in response to ox-LDL stimulus. In conclusion, mir-216a controls ox-LDL induced autophagy in HUVECs by regulating intracellular levels of BECN1 and may have a relevant role in the pathogenesis of cardiovascular disorders and atherosclerosis.


Subject(s)
Atherosclerosis/metabolism , Autophagy , Heart Failure/metabolism , Human Umbilical Vein Endothelial Cells/cytology , Human Umbilical Vein Endothelial Cells/metabolism , MicroRNAs/metabolism , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Atherosclerosis/genetics , Atherosclerosis/physiopathology , Autophagy-Related Protein 5 , Beclin-1 , Heart Failure/genetics , Heart Failure/physiopathology , Humans , Lipoproteins, LDL/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , MicroRNAs/genetics , Microtubule-Associated Proteins/genetics , Microtubule-Associated Proteins/metabolism
4.
Acta Diabetol ; 50(6): 907-10, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23636268

ABSTRACT

Diabetic foot ulceration remains one of the most common and most serious consequences of diabetes. Persistently high levels of matrix metalloproteases (MMPs) contribute to wound chronicity. Our aim was to assess the concentrations of MMPs and tissue inhibitors of metalloproteinases (TIMPs) in neuropathic and ischemic diabetic foot ulcers by analyzing biopsy samples. In this study, biopsies were taken from 35 diabetic foot ulcers of type 2 diabetes mellitus patients and distinguished in neuropathic (n = 14) or ischemic (n = 21). Zymography assay was utilized for the analysis of MMP-2 and MMP-9 activity. TACE activity was evaluated by a specific fluorimetric assay. mRNA levels of MMPs as well as TIMPs were detected using quantitative real-time polymerase chain reaction. The activity of MMP9 and A Disintegrin and A MetalloProtease Domain 17/TNF-Alpha Converting Enzyme (ADAM17/TACE) was significantly increased in ischemic compared to neuropathic biopsies. No differences were detected between both groups for the mRNA levels of MMPs as well as of ADAMs. However, TIMP3 mRNA expression was decreased in ischemic samples. The combination of increased activity of MMP9 and ADAM17/TACE with decreased concentrations of TIMP-3 mRNA expression in ischemic diabetic foot ulcers compared to neuropathic samples suggests that the increased proteolytic environment may represent a causative factor in the ulcer progression. New treatment strategies for healing diabetic foot ulcers could be directed toward increasing levels of TIMP3.


Subject(s)
Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/genetics , Diabetic Foot/genetics , Diabetic Neuropathies/genetics , Ischemia/genetics , Tissue Inhibitor of Metalloproteinase-3/genetics , ADAM Proteins/metabolism , ADAM17 Protein , Aged , Aged, 80 and over , Diabetes Mellitus, Type 2/metabolism , Diabetic Foot/complications , Diabetic Foot/metabolism , Diabetic Neuropathies/complications , Diabetic Neuropathies/metabolism , Disease Progression , Down-Regulation , Female , Humans , Ischemia/complications , Ischemia/metabolism , Male , Middle Aged , Tissue Inhibitor of Metalloproteinase-3/metabolism
5.
J Cell Mol Med ; 12(5B): 2096-106, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18208559

ABSTRACT

Molecular scanning of human insulin receptor substrate (Irs) genes revealed a single lrs1 prevalent variant, a glycine to arginine change at codon 972 (G972R); previous in vitro studies had demonstrated that the presence of this variant results in an impaired activation of the insulin signalling pathway, while human studies gave controversial results regarding its role in the pathogenesis of insulin resistance and related diseases. To address in vivo impact of this IRS-1 variant on whole body glucose homeostasis and insulin signalling, we have generated transgenic mice overexpressing it (Tg972) and evaluated insulin action in the liver, skeletal muscle and adipose tissue and assessed glucose homeostasis both under a normal diet and a high-fat diet. We found that Tg972 mice developed age-related glucose and insulin intolerance and hyperglycaemia, with insulin levels comparatively low. Glucose utilization and insulin signalling were impaired in all key insulin target tissues in Tg972 mice. There were no differences in pancreatic morphology between Tg972 and wild-type mice, however when insulin secretion was evaluated in isolated islets, it was significantly reduced in Tg972 mice islets at any glucose concentration tested. Under a high-fat diet, Tg972 mice had increased body and adipose tissue weight, and were more prone to develop diet-induced glucose and insulin intolerance. So, we believe that Tg972 mice may represent a useful model to elucidate the interaction between genetic and environmental factors in insulin resistance pathogenesis. Furthermore, they may become an important tool to test novel tailored therapies.


Subject(s)
Hypoglycemic Agents/metabolism , Insulin Receptor Substrate Proteins/metabolism , Insulin/metabolism , Adipokines/metabolism , Adipose Tissue/metabolism , Amino Acid Substitution , Animals , Arginine/metabolism , Glucose/metabolism , Glucose Tolerance Test , Humans , Hypoglycemic Agents/pharmacology , Insulin/pharmacology , Insulin Receptor Substrate Proteins/genetics , Insulin Resistance , Insulin Secretion , Liver/metabolism , Liver Glycogen/analysis , Male , Mice , Mice, Transgenic , Muscle, Skeletal/metabolism , Signal Transduction/drug effects
6.
J Arthroplasty ; 21(4 Suppl 1): 37-9, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16841415

ABSTRACT

As surgeons, we share the common goals of making total knee arthroplasty as reliable, as reproducible, and as durable as we can. For that reason, we are almost compelled to investigate the rotating platform knee because of the contentions that it might improve patellar tracking, decrease lateral release rates, improve flexion, or perhaps give better wear characteristics over the long term. But when we take a step back and carefully examine the scientific data from 20 years of clinical experience with the rotating platform knee, the data speak for itself. To date, there are no demonstrated clinical advantages in regard to wear, survivorship, kinematics, range of motion, or patellar function. The rotating platform design then is really just another knee design, clinically indistinguishable from many well-functioning, fixed-bearing total knee designs.


Subject(s)
Arthroplasty, Replacement, Knee/methods , Prosthesis Design , Range of Motion, Articular/physiology , Humans , Osteolysis/epidemiology , Postoperative Complications/physiopathology , Retrospective Studies , Survivors , Treatment Outcome , Weight-Bearing
7.
Proc Natl Acad Sci U S A ; 96(24): 13956-61, 1999 Nov 23.
Article in English | MEDLINE | ID: mdl-10570180

ABSTRACT

STAT1 is an essential transcription factor for macrophage activation by IFN-gamma and requires phosphorylation of the C-terminal Ser727 for transcriptional activity. In macrophages, Ser727 phosphorylation in response to bacterial lipopolysaccharide (LPS), UV irradiation, or TNF-alpha occurred through a signaling path sensitive to the p38 mitogen-activated protein kinase (p38 MAPK) inhibitor SB203580 whereas IFN-gamma-mediated Ser727 phosphorylation was not inhibited by the drug. Consistently, SB203580 did not affect IFN-gamma-mediated, Stat1-dependent transcription but inhibited its enhancement by LPS. Furthermore, LPS, UV irradiation, and TNF-alpha caused activation of p38 MAPK whereas IFN-gamma did not. An essential role for p38 MAPK activity in STAT1 Ser727 phosphorylation was confirmed by using cells expressing an SB203580-resistant p38 MAPK. In such cells, STAT1 Ser727 phosphorylation in response to UV irradiation was found to be SB203580 insensitive. Targeted disruption of the mapkap-k2 gene, encoding a kinase downstream of p38 MAPK with a key role in LPS-stimulated TNF-alpha production and stress-induced heat shock protein 25 phosphorylation, was without a significant effect on UV-mediated Ser727 phosphorylation. The recombinant Stat1 C terminus was phosphorylated in vitro by p38MAPKalpha and beta but not by MAPK-activated protein kinase 2. Janus kinase 2 activity, previously reported to be required for IFN-gamma-mediated Ser727 phosphorylation, was not needed for LPS-mediated Ser727 phosphorylation, and activation of Janus kinase 2 did not cause the appearance of STAT1 Ser727 kinase activity. Our data suggest that STAT1 is phosphorylated at Ser727 by a stress-activated signaling pathway either through p38 MAPK directly or through an unidentified kinase downstream of p38MAPK.


Subject(s)
DNA-Binding Proteins/metabolism , Interferon-gamma/metabolism , MAP Kinase Signaling System , Mitogen-Activated Protein Kinases/metabolism , Proto-Oncogene Proteins , Serine/metabolism , Trans-Activators/metabolism , Animals , Cell Line , Cell Line, Transformed , Enzyme Activation , Enzyme Inhibitors/pharmacology , Humans , Imidazoles/pharmacology , Intracellular Signaling Peptides and Proteins , Janus Kinase 2 , Lipopolysaccharides/pharmacology , Macrophages/cytology , Macrophages/drug effects , Macrophages/metabolism , Macrophages/radiation effects , Phosphorylation , Protein Serine-Threonine Kinases/metabolism , Protein-Tyrosine Kinases/metabolism , Pyridines/pharmacology , Rabbits , Recombinant Fusion Proteins/metabolism , STAT1 Transcription Factor , Transcription, Genetic/drug effects , Tumor Necrosis Factor-alpha/immunology , Tumor Necrosis Factor-alpha/pharmacology , Ultraviolet Rays , p38 Mitogen-Activated Protein Kinases
8.
Appl Environ Microbiol ; 65(9): 4211-5, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10473436

ABSTRACT

Interest in the production of L-(+)-lactic acid is presently growing in relation to its applications in the synthesis of biodegradable polymer materials. With the aim of obtaining efficient production and high productivity, we introduced the bovine L-lactate dehydrogenase gene (LDH) into a wild-type Kluyveromyces lactis yeast strain. The observed lactic acid production was not satisfactory due to the continued coproduction of ethanol. A further restructuring of the cellular metabolism was obtained by introducing the LDH gene into a K. lactis strain in which the unique pyruvate decarboxylase gene had been deleted. With this modified strain, in which lactic fermentation substituted completely for the pathway leading to the production of ethanol, we obtained concentrations, productivities, and yields of lactic acid as high as 109 g liter(-1), 0.91 g liter(-1) h(-1), and 1.19 mol per mole of glucose consumed, respectively. The organic acid was also produced at pH levels lower than those usual for bacterial processes.


Subject(s)
Genetic Engineering , Kluyveromyces/enzymology , Kluyveromyces/genetics , L-Lactate Dehydrogenase/genetics , Lactic Acid/metabolism , Animals , Bioreactors , Cattle , Hydrogen-Ion Concentration , L-Lactate Dehydrogenase/metabolism , Plasmids , Pyruvate Decarboxylase/genetics , Pyruvate Decarboxylase/metabolism , Transformation, Bacterial
9.
Yeast ; 15(5): 361-70, 1999 Mar 30.
Article in English | MEDLINE | ID: mdl-10219994

ABSTRACT

The yeast Kluyveromyces lactis has a single structural gene coding for pyruvate decarboxylase (KIPDC1). In order to study the regulation of the expression of KIPDC1, we have sequenced (EMBL Accession No. Y15435) its promoter and have fused the promoter to the reporter gene lacZ from E. coli. Transcription analysis in a Klpdc1 delta strain showed that KIPDC1 expression is subject to autoregulation. The PDC1 gene from Saccharomyces cerevisiae was able to complement the Rag- phenotype of the Klpdc1 delta mutant strain and it could also repress transcription of the KIPDC1-lacZ fusion on glucose. A deletion analysis of the promoter region was performed to study carbon source-dependent regulation and revealed that at least two cis-acting regions are necessary for full induction of gene expression on glucose. Other cis-elements mediate repression on ethanol.


Subject(s)
Gene Expression Regulation, Fungal , Kluyveromyces/enzymology , Kluyveromyces/genetics , Promoter Regions, Genetic , Pyruvate Decarboxylase/genetics , Pyruvate Decarboxylase/metabolism , Blotting, Northern , Gene Deletion , Genes, Fungal , Genes, Reporter , Genetic Complementation Test , Glucose/metabolism , Homeostasis , Lac Operon , Molecular Sequence Data , Recombinant Fusion Proteins , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...